Aveanna Healthcare (NASDAQ:AVAH) Price Target Raised to $6.75

Key Points

• UBS Group raised Aveanna Healthcare's price target from $5.00 to $6.75, while maintaining a "sell" rating, indicating a potential downside of 4.92% from the current price.
• Multiple analysts have varying ratings for Aveanna, with Jefferies more optimistic after upgrading to a "buy" rating, while Truist Financial lowered their target price to $5.00.
• Aveanna Healthcare's share price increased to $7.10, reflecting recent market activity, while institutional investors control approximately 87.96% of the company's stock.

Aveanna Healthcare (NASDAQ:AVAH - Free Report) had its price objective increased by UBS Group from $5.00 to $6.75 in a report published on Tuesday,Benzinga reports. The firm currently has a sell rating on the stock.

AVAH has been the subject of a number of other research reports. Truist Financial cut their price target on Aveanna Healthcare from $6.00 to $5.00 and set a "hold" rating for the company in a research note on Wednesday, July 16th. Barclays started coverage on Aveanna Healthcare in a research report on Wednesday, July 2nd. They set an "equal weight" rating and a $5.50 price objective for the company. Raymond James Financial upgraded Aveanna Healthcare from a "hold" rating to a "moderate buy" rating and set a $9.00 price objective for the company in a research report on Monday. Wall Street Zen upgraded Aveanna Healthcare from a "buy" rating to a "strong-buy" rating in a research report on Saturday, August 9th. Finally, Jefferies Financial Group upgraded Aveanna Healthcare from a "hold" rating to a "buy" rating and cut their price objective for the company from $6.25 to $6.00 in a research report on Monday, July 21st. One research analyst has rated the stock with a sell rating, two have assigned a hold rating, one has issued a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, the company currently has an average rating of "Hold" and an average price target of $6.45.

Aveanna Healthcare Stock Up 0.7%

AVAH stock traded up $0.05 during trading on Tuesday, reaching $7.20. The company's stock had a trading volume of 1,535,305 shares, compared to its average volume of 1,403,852. Aveanna Healthcare has a 1 year low of $3.67 and a 1 year high of $7.61. The company has a market capitalization of $1.50 billion, a P/E ratio of 90.00 and a beta of 1.95. The company's fifty day moving average is $4.74 and its 200-day moving average is $4.86.

Insider Buying and Selling

In other Aveanna Healthcare news, insider Patrick A. Cunningham sold 18,500 shares of the firm's stock in a transaction dated Friday, June 13th. The shares were sold at an average price of $4.93, for a total value of $91,205.00. Following the completion of the sale, the insider owned 327,869 shares of the company's stock, valued at $1,616,394.17. This trade represents a 5.34% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, major shareholder Paul R. Vigano sold 1,560,700 shares of the firm's stock in a transaction dated Monday, May 19th. The stock was sold at an average price of $5.36, for a total transaction of $8,365,352.00. Following the completion of the sale, the insider directly owned 29,640,756 shares of the company's stock, valued at approximately $158,874,452.16. The trade was a 5.00% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 6,977,245 shares of company stock valued at $37,037,197 in the last quarter. 7.80% of the stock is currently owned by insiders.

Institutional Trading of Aveanna Healthcare

Several institutional investors have recently added to or reduced their stakes in the company. Jane Street Group LLC lifted its stake in Aveanna Healthcare by 74.0% in the second quarter. Jane Street Group LLC now owns 130,675 shares of the company's stock worth $683,000 after purchasing an additional 55,594 shares during the last quarter. Bayesian Capital Management LP bought a new stake in Aveanna Healthcare in the second quarter worth about $85,000. Occudo Quantitative Strategies LP raised its stake in shares of Aveanna Healthcare by 59.7% during the second quarter. Occudo Quantitative Strategies LP now owns 39,517 shares of the company's stock valued at $207,000 after acquiring an additional 14,770 shares in the last quarter. Squarepoint Ops LLC raised its stake in shares of Aveanna Healthcare by 207.0% during the second quarter. Squarepoint Ops LLC now owns 479,977 shares of the company's stock valued at $2,510,000 after acquiring an additional 323,656 shares in the last quarter. Finally, Sei Investments Co. raised its stake in shares of Aveanna Healthcare by 71.1% during the second quarter. Sei Investments Co. now owns 29,271 shares of the company's stock valued at $153,000 after acquiring an additional 12,160 shares in the last quarter. Institutional investors own 87.96% of the company's stock.

About Aveanna Healthcare

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.